These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 7591275)
1. Loss of heterozygosity at 9p21 loci and mutations of the MTS1 and MTS2 genes in human lung cancers. Shimizu T; Sekiya T Int J Cancer; 1995 Nov; 63(5):616-20. PubMed ID: 7591275 [TBL] [Abstract][Full Text] [Related]
2. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma. Sonoda Y; Yoshimoto T; Sekiya T Oncogene; 1995 Nov; 11(10):2145-9. PubMed ID: 7478535 [TBL] [Abstract][Full Text] [Related]
3. Loss of chromosome arm 9p DNA and analysis of the p16 and p15 cyclin-dependent kinase inhibitor genes in human parathyroid adenomas. Tahara H; Smith AP; Gaz RD; Arnold A J Clin Endocrinol Metab; 1996 Oct; 81(10):3663-7. PubMed ID: 8855819 [TBL] [Abstract][Full Text] [Related]
4. Frequent codeletion of p16/MTS1 and p15/MTS2 and genetic alterations in p16/MTS1 in pancreatic tumors. Naumann M; Savitskaia N; Eilert C; Schramm A; Kalthoff H; Schmiegel W Gastroenterology; 1996 Apr; 110(4):1215-24. PubMed ID: 8613012 [TBL] [Abstract][Full Text] [Related]
5. Infrequent mutations and no methylation of CDKN2A (P16/MTS1) and CDKN2B (p15/MTS2) in hepatocellular carcinoma in Taiwan. Lin YW; Chen CH; Huang GT; Lee PH; Wang JT; Chen DS; Lu FJ; Sheu JC Eur J Cancer; 1998 Oct; 34(11):1789-95. PubMed ID: 9893670 [TBL] [Abstract][Full Text] [Related]
6. Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies. Ogawa S; Hangaishi A; Miyawaki S; Hirosawa S; Miura Y; Takeyama K; Kamada N; Ohtake S; Uike N; Shimazaki C Blood; 1995 Aug; 86(4):1548-56. PubMed ID: 7632963 [TBL] [Abstract][Full Text] [Related]
7. Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood. Takeuchi S; Bartram CR; Seriu T; Miller CW; Tobler A; Janssen JW; Reiter A; Ludwig WD; Zimmermann M; Schwaller J Blood; 1995 Jul; 86(2):755-60. PubMed ID: 7606004 [TBL] [Abstract][Full Text] [Related]
8. Multiple tumor-suppressor gene 1 inactivation is the most frequent genetic alteration in T-cell acute lymphoblastic leukemia. Cayuela JM; Madani A; Sanhes L; Stern MH; Sigaux F Blood; 1996 Mar; 87(6):2180-6. PubMed ID: 8630377 [TBL] [Abstract][Full Text] [Related]
9. Intragenic mutations of the p16(INK4), p15(INK4B) and p18 genes in primary non-small-cell lung cancers. Rusin MR; Okamoto A; Chorazy M; Czyzewski K; Harasim J; Spillare EA; Hagiwara K; Hussain SP; Xiong Y; Demetrick DJ; Harris CC Int J Cancer; 1996 Mar; 65(6):734-9. PubMed ID: 8631583 [TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors. Heidenreich A; Gaddipati JP; Moul JW; Srivastava S J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401 [TBL] [Abstract][Full Text] [Related]
11. Deletion and transfection analysis of the p15/MTS2 gene in malignant gliomas. Tenan M; Benedetti S; Finocchiaro G Biochem Biophys Res Commun; 1995 Dec; 217(1):195-202. PubMed ID: 8526910 [TBL] [Abstract][Full Text] [Related]
12. MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme. Moulton T; Samara G; Chung WY; Yuan L; Desai R; Sisti M; Bruce J; Tycko B Am J Pathol; 1995 Mar; 146(3):613-9. PubMed ID: 7887443 [TBL] [Abstract][Full Text] [Related]
13. Chromosome 9p deletions in invasive and noninvasive nonfunctional pituitary adenomas: the deleted region involves markers outside of the MTS1 and MTS2 genes. Farrell WE; Simpson DJ; Bicknell JE; Talbot AJ; Bates AS; Clayton RN Cancer Res; 1997 Jul; 57(13):2703-9. PubMed ID: 9205080 [TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of a family of cyclin-dependent kinase inhibitor genes (p15/MTS2/INK4b and p18/INK4c) in non-small cell lung cancers. Kawamata N; Miller CW; Koeffler HP Mol Carcinog; 1995 Dec; 14(4):263-8. PubMed ID: 8519415 [TBL] [Abstract][Full Text] [Related]
15. Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers. Yoshida S; Todoroki T; Ichikawa Y; Hanai S; Suzuki H; Hori M; Fukao K; Miwa M; Uchida K Cancer Res; 1995 Jul; 55(13):2756-60. PubMed ID: 7796400 [TBL] [Abstract][Full Text] [Related]
16. Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia. Hatta Y; Hirama T; Miller CW; Yamada Y; Tomonaga M; Koeffler HP Blood; 1995 May; 85(10):2699-704. PubMed ID: 7742529 [TBL] [Abstract][Full Text] [Related]
17. Mechanism of inactivation of CDKN2 and MTS2 in non-small cell lung cancer and association with advanced stage. Nakagawa K; Conrad NK; Williams JP; Johnson BE; Kelley MJ Oncogene; 1995 Nov; 11(9):1843-51. PubMed ID: 7478613 [TBL] [Abstract][Full Text] [Related]
18. Methylation of the multi tumor suppressor gene-2 (MTS2, CDKN1, p15INK4B) in childhood acute lymphoblastic leukemia. Iravani M; Dhat R; Price CM Oncogene; 1997 Nov; 15(21):2609-14. PubMed ID: 9399648 [TBL] [Abstract][Full Text] [Related]
19. Genomic DNA and messenger RNA expression alterations of the CDKN2B and CDKN2 genes in esophageal squamous carcinoma cell lines. Zhou X; Suzuki H; Shimada Y; Imamura M; Yin J; Jiang HY; Tarmin L; Abraham JM; Meltzer SJ Genes Chromosomes Cancer; 1995 Aug; 13(4):285-90. PubMed ID: 7547637 [TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity at chromosome 9p21 in primary neuroblastomas: evidence for two deleted regions. Marshall B; Isidro G; Martins AG; Boavida MG Cancer Genet Cytogenet; 1997 Jul; 96(2):134-9. PubMed ID: 9216721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]